AACR Cancer Progress Report
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreFor Alejandro Mirazo, participation in a study looking at genetic risks for disease may have been lifesaving. The study identified his Lynch syndrome, and a follow-up colonoscopy led to a diagnosis of colon cancer.
Read Alejandro’s StoryNearly 153,000 people in the U.S. were diagnosed with colorectal cancer last year. Read about the prevention, screening, and treatment options for this type of cancer.
Learn MoreCan a Vaccine Prevent Colorectal Cancer? Researchers are testing an experimental vaccine designed to prevent colorectal cancer in patients with a history of precancerous polyps know as adenomas.
Read the AACR BlogRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowRegister now to attend the most important cancer meeting of the year.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
